Hernández-Cuervo P, Flores-Chávez A, Ramírez-Villafaña M, Dávalos-de la Cruz P, Romero-Moreno JR, González-Ponce F, Enríquez-Luna A, Contreras-Haro B, Gámez-Nava JI

Language: Spanish
References: 13
Page: 3-9
PDF size: 260.64 Kb.

ABSTRACT

Objective: To describe the frequency of metabolic syndrome (MetS) and associated factors in adult women beneficiaries of the Instituto Mexicano del Seguro Social (IMSS) in Guadalajara. Material and methods: Cross-sectional study. 121 adult women treated in the IMSS between June 2014 and June 2015 were evaluated. MetS diagnosing was performed with NCEP-ATPIII criteria. The point prevalence was obtained. Participants were classified into two groups: with and without metabolic syndrome; a subsequent analysis of associated factors was performed. Results: The prevalence of MetS in this sample was 32%. Factors associated with the presence of MetS were smoking (OR = 8.1, CI 1.0-68.9, p = 0.02) and lower education (OR = 5.5 CI 2.2-13.5, p ‹ 0.001). Conclusion: The frequency of MetS in this sample of women is elevated. The increased risk of developing cardiovascular disease in the medium term in patients with MetS is known, and it is one of the leading causes of death in adult women affiliated to the IMSS. Efforts for prevention, early detection of the entities that make up the MetS and timely and continuous treatment are required.

REFERENCES

1. García E, De la Llata M, Kaufer M, Tusié MT, Calzada R, Vázquez V. Obesity and the metabolic syndrome as a public health problem: a reflection. Salud Pública Méx. 2008; 50: 530-547.

2. Olaiz G, Rivera J, Shamah T, Rojas R, Villalpando S. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, 2006.

3. Ferraz AI, González CJ, López MR, Riancho ZL, González GM. Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm. 2013; 2013: 710928.

4. Isomaa B, Almgren P, Tuomi T. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24: 683-689.

5. Stern MP, Williams K, Gonzalez VC, Hunt KJ, Haffner SM. Does the metabolic-syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004; 27: 2676-2681.

6. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Bethesda, Md: National Heart, Lung, and Blood Institute. Circulation. 2002; 106: 3143-3421.

7. American Diabetes Association. Standards of medical care in diabetes 2014. Diabetes Care. 2014; 37 (Suppl 1): S14-S80.

8. Cruz CAH, García FR, Hess MMI, Vigil PCA, Córdova FJA et al. Metabolic syndrome prevalence and clinical features in blood donors. Rev Fac Cien Med Univ Nac Cordoba. 2012; 3: 144-149.

9. Mathiew QA, Salinas MAM, Hernández HRJ, Gallardo VJA. Síndrome metabólico en trabajadores de un hospital de segundo nivel. Rev Med Inst Mex Seguro Soc. 2014; 5: 580-587.

10. Meaney A, Ceballos RG, Gutiérrez G, Samaniego V, Vela A. Cardiovascular risk factors in a Mexican middle-class urban population. Arch Cardiol Mex. 2013; 83 (4): 249-256.

11. Isordia SI, Santiago GD, Rodríguez NH, Almaraz DN, Leaños MA et al. Prevalence of metabolic syndrome components in a Mexican sample: comparison between two classifications. Exp Diabetes Res. 2012; 2012: 202540.

12. Rojas R, Aguilar SCA, Jiménez CA, Shamah LT, Rauda J, Ávila BL. Metabolic syndrome in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Pública Mex. 2010; 52: S11-18.

13. Salas R, Bibiloni MM, Ramos E, Villareal JZ, Pons A. Metabolic syndrome prevalence among Northern Mexican Population. PLoS One. 2014; 9 (8): e105581.